Core Insights - Elevance Health, Inc. (NYSE:ELV) is reaffirming its full-year 2025 earnings guidance, expecting earnings of approximately $24.10 per diluted share, which includes about $5.90 per share in net unfavorable items, leading to adjusted earnings of roughly $30.00 per diluted share when excluding these items [2][3] Group 1 - The company anticipates a benefit expense ratio close to 90% for the year, based on current market conditions, regulatory factors, and medical cost trends [3] - Elevance Health operates under several brands, including Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon, providing health benefits, pharmacy, and healthcare services across the U.S. [3] - Elevance Health is recognized as one of the best Roth IRA stocks to invest in currently [1][3]

Core Viewpoint - The article discusses the 11 best stocks to invest in through a Roth IRA, emphasizing the importance of selecting the right stocks for long-term wealth creation in an uncertain economic environment [1][4]. Investment Strategy - A Roth IRA allows for tax-free investment growth and withdrawals, making it a powerful tool for long-term wealth creation, especially for individuals aged 35 to 60 [2]. - The selection of stocks for a Roth IRA is crucial, particularly in light of recent market volatility and economic uncertainty [3]. Market Context - On September 5, 2025, major market indexes experienced declines following a weaker-than-expected jobs report, raising concerns about economic growth [3]. - The S&P 500 fell by 0.32%, the Dow decreased by 220 points, and the Nasdaq dropped by 0.03%, despite reaching record intraday highs earlier in the session [3]. Methodology for Stock Selection - The list of the 11 best Roth IRA stocks was curated based on long-term growth catalysts, dividend growth history, solid business fundamentals, and positive analyst coverage [6]. - Hedge fund sentiment was assessed using Insider Monkey's hedge fund database, which tracks over 1,000 hedge funds, ranking stocks based on the number of hedge funds holding stakes as of Q2 2025 [6][7]. Featured Stocks - **NextEra Energy, Inc. (NYSE:NEE)**: - Number of Hedge Fund Holders: 66 - Goldman Sachs reaffirmed a 'Buy' rating with a price target of $91.00, highlighting the company's strong regulatory navigation and gradual rate increases [9][10][11]. - **Honeywell International Inc. (NASDAQ:HON)**: - Number of Hedge Fund Holders: 67 - Announced a $600 million equity capital raise for its quantum subsidiary, Quantinuum, valuing it at $10 billion pre-money, aimed at accelerating the development of next-generation quantum computing [13][14][15]. - **Elevance Health, Inc. (NYSE:ELV)**: - Number of Hedge Fund Holders: 67 - Expected to reaffirm full-year 2025 earnings guidance of approximately $24.10 per diluted share, with adjusted earnings projected at around $30.00 per diluted share [17][18].

Group 1: Market Overview - The market has experienced sharp volatility recently, but not all stocks have been negatively impacted, with UnitedHealth (UNH), Newmont (NEM), and Sprouts Farmers Market (SFM) showing positive gains [1][8]. Group 2: Newmont (NEM) - Newmont is one of the largest gold producers globally, with active mines in Nevada, Peru, Australia, and Ghana, benefiting from a surge in gold prices, resulting in a nearly 50% year-to-date performance increase [4]. - The average gold price per ounce reached $2,643, up from $2,004 in the same period last year, contributing to a record free cash flow of $1.6 billion [5]. - Analysts have raised their EPS expectations for Newmont, reflecting a bullish near-term outlook [7]. Group 3: UnitedHealth (UNH) - UnitedHealth provides a comprehensive range of health benefits, with its Optum segment leveraging data and technology to enhance care delivery and health outcomes [9]. - The company is expected to report a 5% year-over-year EPS growth on 11% higher sales, having exceeded EPS estimates in the last 20 quarterly releases [10][11]. - UnitedHealth's domestic operations provide a buffer against tariff concerns [11]. Group 4: Sprouts Farmers Market (SFM) - SFM has shown strong performance, exceeding consensus EPS and sales expectations for the last ten quarters, with a stock increase of nearly 160% over the past year [12]. - The company reported $2.0 billion in sales, reflecting a 17% year-over-year growth, indicating strong demand [14]. - SFM holds a Zacks Rank 1 (Strong Buy), with a notably bullish EPS outlook [15]. Group 5: Conclusion - Despite ongoing market volatility and tariff headlines, UnitedHealth, Newmont, and Sprouts Farmers Market have all demonstrated upward momentum and possess bullish near-term EPS outlooks [16].

Core Insights - Earnings season is crucial for investors, with a focus on guidance due to recent tariff-induced uncertainties [1] - Notable large-cap stocks reporting this week include Progressive (PGR) and UnitedHealth (UNH), both showing strong relative performance in 2025 [1][7] UnitedHealth (UNH) Summary - UnitedHealth Group provides a comprehensive range of health benefits, leveraging data and technology through its Optum segment to enhance care delivery and health outcomes [4] - The company holds a Zacks Rank 2 (Buy), with stable earnings estimate revisions and expected 5% EPS growth on 11% higher sales [4] - Current trading at a 19.5X forward 12-month earnings multiple, aligning with the five-year median and below the five-year high of 26.6X; PEG ratio stands at 1.6X, slightly above the five-year median of 1.4X [6] Progressive (PGR) Summary - Progressive is a leading auto and property insurer in the U.S., recognized for its direct-to-consumer model and strong underwriting performance [9] - The stock also holds a Zacks Rank 2 (Buy), with earnings expectations rising significantly, up 27% over the last 60 days [9] - Projected to see a 27% year-over-year increase in EPS on nearly 20% higher sales, with a history of exceeding Zacks Consensus EPS estimates by an average of 18% in the last four releases [10] - Currently trading at a 17.6X forward 12-month earnings multiple, compared to a five-year median of 19.3X and a five-year high of 31.9X [10] Overall Market Context - The Q1 earnings season for 2025 is gaining momentum, with Progressive and UnitedHealth as key players [13] - Both companies are relatively insulated from tariff concerns due to their domestic operations, which is a significant advantage in the current political climate [13]